RxDoctor Payments Data

Lawrence Anaya, MD

Family Medicine · Pueblo, CONPI 1245395649

Payments from drug & device makers

$4,655in general payments, 2019–2025

Across 295 payments — averaging $15.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$911
  • AstraZeneca$775
  • AbbVie$435
  • Amgen$296
  • GSK$265
  • Lilly USA, LLC$252
  • plus $2K from 34 others

What the payments were for

  • Food & beverage$4,59199%
  • Education$651%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,655 in reported general payments places this provider in the 90th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$194,813
Medicare patients
479
Services billed
6,135

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban55$61,456
OzempicSemaglutide31$50,895
JanuviaSitagliptin Phosphate26$26,378
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$23,382
ShingrixVaricella-Zoster Ge/As01b/Pf85$18,951
Tresiba Flextouch U-200Insulin Degludec13$13,504
Spiriva RespimatTiotropium Bromide21$13,201
ArexvyRsvpref3 Antigen/As01e/Pf36$11,140
JardianceEmpagliflozin17$9,517
Fluticasone-SalmeterolFluticasone Propion/Salmeterol24$5,201
Adacel TdapDiph,pertuss(Acell),tet Vac/Pf63$4,464
Levothyroxine Sodium281$3,049
Atorvastatin Calcium309$2,448
Tamsulosin Hcl170$2,444
Omeprazole239$2,341

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$128$61,45655 claims
GSKTrelegy Ellipta, Shingrix, Arexvy$265$53,473148 claims
Novo NordiskOzempic$911$50,89531 claims
MerckJanuvia$176$26,37826 claims
Boehringer IngelheimSpiriva Respimat, Jardiance$66$22,71838 claims
AbbVieSynthroid$435$87726 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Pueblo

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →